Evolución y salud: evolución experimental y epidemiología
EVOSALUD
Centro Nacional de Biotecnología
Madrid, EspañaCentro Nacional de Biotecnología -ko ikertzaileekin lankidetzan egindako argitalpenak (9)
2024
-
Functional antibody responses targeting the Spike protein of SARS-CoV-2 Omicron XBB.1.5 in elderly nursing home residents following Wuhan-Hu-1-based mRNA booster vaccination
Scientific reports, Vol. 14, Núm. 1, pp. 11896
-
Isolation and characterization of two novel bacteriophages against carbapenem-resistant Klebsiella pneumoniae
Frontiers in Cellular and Infection Microbiology, Vol. 14
2023
-
Antibody-dependent NK-cell and neutralizing antibody responses against the Spike protein of Wuhan-Hu-1 and Omicron BA.1 SARS-CoV-2 variants in vaccinated experienced and vaccinated naïve individuals
Journal of medical virology, Vol. 95, Núm. 7, pp. e28900
-
C-2 Thiophenyl Tryptophan Trimers Inhibit Cellular Entry of SARS-CoV-2 through Interaction with the Viral Spike (S) Protein
Journal of Medicinal Chemistry, Vol. 66, Núm. 15, pp. 10432-10457
2022
-
Rapid and direct quantification of the SARS-CoV-2 virus with an ultrasensitive nanobody-based photonic nanosensor
Sensors and Diagnostics, Vol. 1, Núm. 5, pp. 983-993
-
The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation
PLoS Pathogens, Vol. 18, Núm. 7 July
2017
-
The Evolution of Antibiotic Resistance
Genetics and Evolution of Infectious Diseases: Second Edition (Elsevier Inc.), pp. 257-284
2014
2011
-
The Evolution of Antibiotic resistance
Genetics and Evolution of Infectious Diseases (Elsevier Inc.), pp. 305-337